Insmed Inc. INSM
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Insmed Inc. is a global biopharmaceutical company focused on developing and commercializing therapies for patients with serious and rare diseases. The company concentrates its activities across three key therapeutic areas: respiratory, immunology and inflammation, and neuro and other rare conditions. Insmed’s commercia…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees1,664
TickerINSM
Statistics
Market Cap$21.27B
Revenue (TTM)$606.4M
Net Income-$1.28B
Net Margin-210.5%
EPS$-6.42
P/E-15.06
P/S25.58
P/B29.71
EV/EBITDA-20.48
ROE-294.5%
Dividend Yield—
Price$98.23
Data: Twelve Data · Revenue = mcap / P/S